Senti Biosciences Inc at Morgan Stanley Global Healthcare Conference Transcript
I'm Michael, one of the biotech analysts here, and it's my pleasure to introduce the team from Senti Biosciences, including Tim Liu, CEO; Deb Knobelman, CFO; and Kanya Rajangam, Head of R&D and CMO. I'm sorry about that. Just a reminder, format's fireside chat, I just need to read a quick disclosure before we get started. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative. And with that, thanks for joining us. And maybe, Tim, I can just turn it over to you to make some quick intro.
Yeah. Thanks a lot for the opportunity. I just wanted to give a bit of an overview what Senti is and what we're focused on doing. So Senti is a biotechnology company really focused on solving what we view as a central problems in
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
